July 2020
Volume 61, Issue 9
Free
ARVO Imaging in the Eye Conference Abstract  |   July 2020
Detection of Venous Loops in Diabetic Retinopathy using Widefield Swept-Source Optical Coherence Tomography Angiography
Author Affiliations & Notes
  • Rongrong Le
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Department of Glaucoma, Wenzhou Medical University affiliated eye hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Ying Cui
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Department of Ophthalmology, Guangdong Eye Institute,Guangdong Provincial People’s Hospital, Guangzhou, Guangdong, China
  • Ying Zhu
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha, China
  • Jay Wang
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Yifan Lu
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Rebecca Zeng
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Boston University School of Medicine, Boston, Massachusetts, United States
  • Raviv Katz
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Inês Laíns
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Itika Garg
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • David Wu
    Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States
  • Dean Eliott
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Demetrios Vavvas
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Deeba Husain
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Joan Miller
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Leo Kim
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • John Miller
    Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Rongrong Le, None; Ying Cui, None; Ying Zhu, None; Jay Wang, None; Yifan Lu, None; Rebecca Zeng, None; Raviv Katz, None; Inês Laíns, None; Itika Garg, None; David Wu, None; Dean Eliott, None; Demetrios Vavvas, None; Deeba Husain, None; Joan Miller, Genentech/Roche (C), Genentech/Roche (R), KalVista Pharmaceuticals (C), Lowy Medical Research Institute (F), ONL Therapeutics (C), ONL Therapeutics (P), ONL Therapeutics (I), Sunovion (C), Valeant Pharmaceuticals/Mass. Eye and Ear (P), Valeant Pharmaceuticals/Mass. Eye and Ear (R); Leo Kim, None; John Miller, Carl Zeiss Meditec, Inc. (C), Heidelberg Engineering Inc. (C)
  • Footnotes
    Support  Lions International Fund MEE PS# 2100550
Investigative Ophthalmology & Visual Science July 2020, Vol.61, PP009. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rongrong Le, Ying Cui, Ying Zhu, Jay Wang, Yifan Lu, Rebecca Zeng, Raviv Katz, Inês Laíns, Itika Garg, David Wu, Dean Eliott, Demetrios Vavvas, Deeba Husain, Joan Miller, Leo Kim, John Miller; Detection of Venous Loops in Diabetic Retinopathy using Widefield Swept-Source Optical Coherence Tomography Angiography. Invest. Ophthalmol. Vis. Sci. 2020;61(9):PP009.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal venous loops (RVL) are rare manifestations of diabetic retinopathy (DR) usually identified by color fundus photography. The prevalence and its predictive value reported in the literature may be underestimated due to the limitations of detection techniques. This study investigated the prevalence of RVL and their associated microvascular changes using widefield swept-source optical coherence tomography angiography (WF SS-OCTA).

Methods : In this retrospective, observational study at Mass Eye and Ear from December 2018 to December 2019, diabetic patients with proliferative diabetic retinopathy (PDR), non-proliferative diabetic retinopathy (NPDR) and without DR were included. All patients were imaged with a WF SS-OCTA using Angio 6mm×6mm and Montage 15mm×15mm scan. Images were independently evaluated by two graders for the presence or absence of RVL and other DR lesions including nonperfusion areas (NPAs) and neovascularization (NV). RVL were divided into two types according to the branching level of the feeder vessel. Type I has loops on the larger veins encompassing the third and second branching level from the central retinal vein; type II has loops on the fourth or higher branching level

Results : Two hundred and thirty-three eyes of 156 diabetic patients, with no DR (n =31 eyes), NPDR (n = 98 eyes) and PDR (n = 104 eyes), were included in this study. The prevalence of RVL in DM and PDR was 11.2 % (26/233) and 19.2% (20/104), respectively. There were significantly more eyes with RVL in PDR than NPDR (p<0.05). Type I RVL occurred in 5 eyes, while 23 eyes with type II RVL. Although none of the RVL were found to have adjacent NV, the rate of accompanied NPAs in type I RVL was higher than that in type II (6/7, 85% vs 8/19, 42%, p<0.05).

Conclusions : WF SS-OCTA is useful for identification of RVL in patients with DR. Given the increased prevalence of RVL in more advanced diabetic retinopathy, RVL may represent another referable feature as part of a potential OCTA screening system for diabetic eye disease. Larger longitudinal studies will be needed to assess the relationship between RVL with NPAs and NV on OCTA.

This is a 2020 Imaging in the Eye Conference abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×